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Integration of ‘omics’ data in aging research: from biomarkers
to systems biology
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Tim D. Spector1
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London, London, United Kingdom
2Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum
Mu¨nchen, Neuherberg, Germany
Summary
Age is the strongest risk factor for many diseases including
neurodegenerative disorders, coronary heart disease, type 2 dia-
betes and cancer. Due to increasing life expectancy and low birth
rates, the incidence of age-related diseases is increasing in indus-
trialized countries. Therefore, understanding the relationship
between diseases and aging and facilitating healthy aging are
major goals in medical research. In the last decades, the dimension
of biological data has drastically increased with high-throughput
technologies nowmeasuring thousands of (epi) genetic, expression
and metabolic variables. The most common and so far successful
approach to the analysis of these data is the so-called reductionist
approach. It consists of separately testing each variable for associ-
ation with the phenotype of interest such as age or age-related
disease. However, a large portion of the observed phenotypic
variance remains unexplained and a comprehensive understanding
of most complex phenotypes is lacking. Systems biology aims to
integratedata fromdifferent experiments togainanunderstanding
of the system as awhole rather than focusing on individual factors.
It thusallowsdeeper insights into themechanismsof complex traits,
which are caused by the joint influence of several, interacting
changes in the biological system. In this review, we look at the
current progress of applying omics technologies to identify
biomarkers of aging. We then survey existing systems biology
approaches that allow for an integration of different types of data
and highlight the need for further developments in this area to
improve epidemiologic investigations.
Key words: data integration; graphical models; high-
throughput data; omics; systems biology.
Introduction
Aging is often described as the progressive accumulation of changes
with time leading to a loss of physiological aptitude and fertility, an
increased susceptibility to disease and ultimately to death (Harman,
1988, 2001; Kirkwood & Austad, 2000; Vijg & Suh, 2005; Lopez-Otın
et al., 2013). Despite considerable effort and the development of many
theories, the underlying process is still largely unknown (Kirkwood &
Austad, 2000; Weinert & Timiras, 2003; Rattan, 2006).
Researchers distinguish between chronological and biological age.
Chronological age is defined as the absolute time that an individual lives.
In contrast, biological age is a broader concept that takes the individual
physical and mental health into account, thus capturing individual
differences of the aging process. Most aging studies search for
associations of chronological age with clinical and molecular phenotypes
(Warming et al., 2002). However, several studies used phenotypes, such
as lung function, grip strength or bone mineral density, as proxies to
investigate molecular changes in biological aging (Jackson et al., 2003;
Bell et al., 2012; Levine, 2013). Researchers also investigated reasons of
retarded biological aging and longevity by comparing centenarians with
younger controls (Biagi et al., 2012; Sebastiani et al., 2012).
The life expectancy in the UK increased by 5.3 years for men and 4.7
for women over the last two decades and is predicted to further increase
in the next twenty years (Oeppen & Vaupel, 2002; Office for National
Statistics 2014). With increasing life expectancy, age-related diseases are
expected to rise dramatically (700 000 people suffered from dementia in
2000, 800 000 in 2012 and approximately 1 million people will be
affected by dementia in 2021 (Alzheimer’s Society 2014)) with major
impacts on healthcare costs. Thus, a better understanding of aging and
its influence on disease is a long term public health goal and a hot topic
of current medical research.
Omics technologies provide valuable tools to study aging on the
molecular level. Reductionist data analyses, testing the measured
variables separately for association with age, have been extensively
applied. Such studies successfully identified hundreds of epigenetic
mutations, gene expression levels, metabolite concentrations to be
linked with chronological and/or biological age (see below for details).
Even though these results improved our understanding of aging as a
complex phenotype, the mechanisms underlying these associations and
the impact of interactions between different biological entities remain
elusive in most cases. In contrast to reductionist approaches, systems
biology aims to analyse all components of a biological process
simultaneously taking into account their interactions and their intrinsic
hierarchical structure (Ideker et al., 2001; Baraba´si & Oltvai, 2004). With
more and more high-throughput data becoming available, systems
biology has led to many new methods and their successful application on
age and age-related phenotypes (as outlined below).
In this review, we will briefly summarize the current progress in
‘omics’ technologies and their application in aging research. We will
then highlight some problems of the reductionist approach and discuss
how these may be overcome using systems biology. We present a
selection of statistical methods used in systems biology along with their
current and possible future applications in the field of aging research to
move from biomarkers of aging to a more holistic understanding of the
aging process.
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Omics and aging
New technologies allow the measurement of ‘omics’ data and numerous
association studies have been conducted. Valdes et al. (2013) thor-
oughly reviewed the application of these technologies to identify
molecular markers of aging from each omics level. Therefore, the
following section will only briefly highlight some key results and
concentrate on recent findings.
Genomics
Genomics was the first omics field for which high-throughput measure-
ments became available. Current chips are able to measure up to 5
million single nucleotide polymorphisms (SNPs) (Ha et al., 2014). Today,
next-generation sequencing technology is slowly replacing the chip
technology as the cost of sequencing has dropped below $0.10 per
million bp (Liu et al., 2012). Thus, gene variation is nowadays often
available at single nucleotide resolution.
While aging (or rather longevity) itself was found to be only about
20% heritable (Murabito et al., 2012), many age-related diseases are
highly heritable. For instance, Alzheimer’s disease (AD) shows a
heritability above 70% (Gatz et al., 2006) and osteoarthritis (Ishimori
et al., 2010) or cataract show 50% heritability (Hammond et al., 2001).
The GenAge database contains about 300 human candidate genes
for aging based on homology with model organisms (Tacutu et al.,
2013). Sebastiani et al. (2012) recently published a refined model
consisting of 281 SNPs to distinguish between centenarians and younger
controls in a cohort of 1715 people. One of these SNPs is located in
ApoE, which is so far the only gene that has been reliably associated with
longevity at genomewide significance level (Deelen et al., 2011; Nebel
et al., 2011). Common genetic variants at this locus have been
associated with accelerated aging and cognitive decline (Johnson,
2006; Davies et al., 2014), possibly by increasing the risk for coronary
artery disease, stroke and AD (Smith, 2002). Even though some studies
provided evidence that mutations of FOXO transcription factors are
related to longevity (Willcox et al., 2008; Flachsbart et al., 2009), as
well, GWASs failed to replicate this at the level of genomewide
significance.
Epigenomics
Epigenomics describes the study of heritable changes in the genome that
are not caused by DNA sequence mutations (Lodish, 2013). The most
common epigenetic mechanism is DNA methylation, which is known to
often silence gene expression. In contrast to the genome, which is the
same in all cells, the epigenome is an important factor of cell
differentiation leading to profound epigenetic differences across differ-
ent cell types (Meissner, 2010). The current methylation chip by Illumina
measures over 485 000 methylation sites and covers 99% of all RefSeq
genes (Illumnia 2011). However, it covers less than 10% of variable
regions (Ziller et al., 2013).
The epigenome is influenced by environmental and lifestyle factors
(Nakajima et al., 2010; Alegrıa-Torres et al., 2011; Breitling et al., 2011)
and is associated with many complex diseases such as neurodegener-
ative disorders (reviewed by Portela & Esteller, 2010) and cancer (Ehrlich,
2002; Horvath, 2013). Nearly 500 differentially methylated regions were
found to be associated with chronological age and age-related pheno-
types such as lung function, cholesterol levels and maternal longevity
(Bell et al., 2012). A recent study by Weidner et al. (2014) showed that
methylation patterns of just three sites are sufficient to predict
chronological age. Thus, many of the previously identified methylation
sites might not be independently associated with age. Interestingly,
variation in methylation with age is consistent across several tissues and
cell types (Horvath, 2013). Together, they form a global pattern of
hypomethylation in repetitive sequences, hypermethylation in promoter
regions and higher intercell variability (Cevenini et al., 2008; Bacalini
et al., 2014). Besides DNA methylation, other epigenetic changes, such
as histone methylation and acetylation, have been found to be
associated with longevity in model organisms (Dang et al., 2009; Greer
et al., 2010). Investigating these modifications in humans could shed
light on so far unknown mechanisms of aging.
Transcriptomics
Genes are transcribed into RNA molecules, which are further processed
in a tightly controlled process. The entirety of the RNA transcripts is
referred to as transcriptome. It can be divided in coding RNAs, which are
further translated in proteins, and noncoding RNAs, which perform
various functions, such as regulation of gene expression (Eddy, 2001).
Transcript abundances can be measured by either chips or sequencing
methods.
Similar to the epigenome, gene expression was shown to dramatically
change with age. A pioneer study comparing postmortem human frontal
cortex tissue samples between 30 individuals of different ages yielded
463 differentially expressed genes (Lu et al., 2004). Despite the small
sample size, results were replicated in subsequent experiments. Four
years later, Berchtold et al. (2008) identified several thousand age-
related changes in gene expression in four different brain tissues. Later
studies by different groups identified profound changes in the tran-
scriptome with age in further tissues, such as skin, adipose tissue
(N = 865) (Glass et al., 2013) and kidney (N = 134) (Rodwell et al.,
2004). Most of these changes did not overlap in different tissues. A
meta-analysis across different species and tissues revealed only 73 genes
consistently associated with age (de Magalh~aes et al., 2009). This
suggests that most observed age-related changes in the transcriptome
are either species and tissue specific or false-positive discoveries
(reviewed by Valdes et al., 2013). In their meta-analysis, genes related
to immune response and lysosome tended to be overexpressed, while
genes related to mitochondria and oxidative phosphorylation were
underexpressed in elderly (de Magalh~aes et al., 2009).
Proteomics
Proteins are translated from coding transcripts. Due to alternative
splicing and post-translational protein modifications, the number of
proteins is estimated to be two orders of magnitudes higher than the
number of genes (Ginsburg & Haga, 2006). However, current proteomic
techniques based on immunoassays, protein arrays or mass spectrometry
can measure only a small fraction of the proteome (up to 1000 proteins
in a sample). The most comprehensive description of the human
proteome across various tissues to date consists of 18 097 proteins
(19 376 isoforms) collected from ten thousand mass spectrometry
experiments (Wilhelm et al., 2014).
Due to these technicalities, ‘proteomics’ studies in aging research so
far focused on smaller sets of proteins and small sample sizes. In an early
study of protein abundance in the vastus lateralis muscle, Gelfi et al.
(2006) observed higher abundance of several proteins involved in
aerobic metabolism and a lower abundance of proteins involved in
anaerobic metabolism in the elderly. Besides this, six transport proteins
were consistently underexpressed in older individuals. However, only 12
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samples were analysed in this study without replication. A recent study
by our group analysed over 1000 proteins in 200 plasma samples using
the SOMAscan assay (Menni et al., 2015). Eleven proteins were found to
strongly associate with chronological age as well as age-related
phenotypes such as lung function and blood pressure. The results were
replicated in an independent cohort.
Even though comprehensive proteomics studies are still missing,
proteins are likely to be associated with several age-related diseases. For
instance, cardiovascular disease (Mehra et al., 2005) and AD (Swardfa-
ger et al., 2010) are consistently associated with elevated levels of pro-
inflammatory cytokines.
Post-translational modifications – glycomics
Post-translational modifications are important elements of proteins,
which can alter their biochemical properties such as protein structure,
binding preferences and enzyme activity. There are many different
modifications ranging from addition of small molecules (e.g. acetylation
or phosphorylation), over addition of larger molecules such as lipids or
sugar chains (e.g. palmitoylation, glycosylation), to the addition of whole
proteins (e.g. ubiquitination).
The most common modification is glycosylation, which attaches sugar
chains to proteins. The attached oligosaccharides – glycans – are
supposed to mainly serve as structural elements of proteins or specific
binding sites for other glycans or proteins (Varki et al., 2009). However,
glycans are highly diverse and many of them are not yet characterized or
annotated. Thus, glycans might have many additional functions. For
example, glycans in the gut act as food for microbes (Koropatkin et al.,
2012), which could be implicated in immune functions that are
important in aging. Recent development allows the high-throughput
measurement of glycans of either a single protein or all proteins
simultaneously (Royle et al., 2008; Pucic´ et al., 2011).
The application of this technology on epidemiological cohorts
revealed that glycan structures are stable for one individual over time
(Gornik et al., 2009) but very diverse within a population (Knezevic´
et al., 2009; Pucic´ et al., 2011). Differences in glycomes were found to
be related with various cancers (Fuster & Esko, 2005; Adamczyk et al.,
2012). Recently, Kristic et al. (2013) showed that IgG glycans are
strongly associated with age: a linear combination of three glycans
explained 58% of the observed variance of chronological age (Kristic
et al., 2013) in a study of four independent populations with 5117
participants in total.
Metabolomics
Metabolomics investigates the low-molecular-weight molecules in a
biological system. The measured molecules are often referred to as
metabolites as many of them act as educts, products and intermediates
of the cellular metabolism. Currently, the Human Metabolome
Database (Wishart et al., 2013) contains more than 40 000 distinct
metabolites from different tissues. Similar to proteomics, to date, there
is no analytical method available to determine and quantify all
metabolites in a single experiment. Current platforms, using either
chromatography coupled with mass spectrometry or nuclear magnetic
resonance, can measure roughly a thousand metabolites in untargeted
settings and a smaller number using predefined targeted approaches.
The restriction of the targeted approach comes with the advantages of
higher sensitivity, absolute instead of relative quantification and
straight-forward compound identification (Patti et al., 2012; Tzoulaki
et al., 2014).
In 2008, the first metabolome-wide association study on age analysed
the plasma metabolome of 269 individuals using an untargeted
approach. The authors found 100 of 300 compounds to correlate with
chronological age (Lawton et al., 2008). More recently, larger cohorts
were employed to study the association of metabolites and age using
both targeted and untargeted metabolomics platforms. Yu et al. (2012)
analysed 131 targeted metabolites in 2162 individuals from the KORA
study, while we analysed 280 untargeted metabolites in 6055 twins
from the TwinsUK cohort (Menni et al., 2013b). Both studies identified
half of the analysed metabolites to be associated with chronological age.
Many of the those metabolites were also found to significantly correlate
with age-related phenotypes such as lung function, bone mineral density
and cholesterol levels (Menni et al., 2013b), AD (N = 93) (Oresic et al.,
2011), cancer (reviewed by Teicher et al., 2012) and type 2 diabetes
(N = 100) (Suhre et al., 2010; Menni et al., 2013a). One of those
metabolites is C-glycosyltryptophan, a potential degradation product of
glycosylated proteins.
Microbiomics
The human microbiome describes the complete set of microbial species
(and their genomes) hosted by the human body. The largest microbial
community resides in the gut, where microbial cells and their genes
outnumber human cells (10:1) and genes (100:1) (Peterson et al., 2009;
Zhu et al., 2010; The Human Microbiome Project 2014a). More than 10
000 different species with millions of protein-coding genes were
identified by the Human Microbiome Project (Turnbaugh et al., 2007;
Peterson et al., 2009; Biagi et al., 2012) and >1000 of these microbes
have so far been fully sequenced (The Human Microbiome Project
2014b). Although twin studies have found a modest genetic influence
on some phyla, most of the variation is environmental (Goodrich et al.,
2014).
The composition of the microbe flora varies a lot across individuals
(Turnbaugh et al., 2007; Zhu et al., 2010) and even between different
parts of the body (Kong, 2011). It has a huge influence on many
biological processes such as immune response, metabolism and disease
(Zhu et al., 2010; Grice & Segre, 2012). While the microbiome seems to
be relatively stable during adulthood, it changes significantly in later life
(Guigoz et al., 2008; Biagi et al., 2010; Claesson et al., 2011). Biagi
et al. (2010) observed drastic changes in the gut microbiome of
centenarians compared with young adults as well as elderly, namely a
general loss of diversity and increased abundance of bacilli and
proteobacteria. The latter were reported to promote inflammation
under certain conditions (Round & Mazmanian, 2009). Similar findings
were revealed in other elderly populations, which also considered the
dietary and residential situation of elderly patients (Claesson et al.,
2012).
Phenomics
Simultaneously with omics data, the dimension of clinical and lifestyle
traits, particularly clinically used intermediate traits, keeps increasing.
Epidemiological studies collected thousands of clinically relevant pheno-
types beyond omics data types. These range from anthropometric
measures to health and lifestyle questionnaires (Moayyeri et al., 2013).
Collecting high-dimensional clinical data is important to unveil pleiotropy
of genes and interactions amongst clinical phenotypes such as comor-
bidities (Houle et al., 2010). Driven by omics technologies, statistical and
bioinformatic methods to analyse high-dimensional data are becoming
available. These facilitate the investigation of numerous clinical
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phenotypes in parallel, thus defining the new field of phenomics (Houle
et al., 2010).
Phenomics is especially important for aging research. Dozens of
clinical phenotypes, such as Parkinson’s (Reeve et al., 2014), AD
(McAuley et al., 2009), body mass index, blood pressure (Mungreiphy
et al., 2011) and bone mineral density (Warming et al., 2002), as well as
lifestyle parameters, such as nutrition (Wieser et al., 2011), smoking and
physical activity, are strongly related to age (Harman, 1988; Wang et al.,
2009). Composite measures such as the Rockwood frailty index
(Rockwood & Mitnitski, 2007) combine several of those clinical traits
to form a more homogenous phenotype – frailty – from its diverse
appearance. Such frailty measures can be considered as measures for
biological age (Mitnitski et al., 2013). Many of these (and other) clinical
phenotypes correlate or even depend on each other (McAuley et al.,
2009; Baylis et al., 2014). Only extensive collection of data and their
joint analysis will help to unveil these dependencies and find causal
relationships.
From omics to systems biology
Most of the studies summarized above concentrated on the bivariate
associations of age (or age-related diseases) with one type of omics data.
However, there are strong interdependencies within and between the
different omics data (see Fig. 1).
Correlations can be observed practically between all levels of biological
organization. Following the central dogma of molecular biology,
genomics, transcriptomics and proteomics are correlated ‘by definition’.
Furthermore, metabolite concentrations are influenced by genetic
variants (Shin et al., 2014) and epigenetic factors (Petersen et al., 2014)
mediated through changes in gene expression or enzyme activity.
Methylation levels do not only influence the gene expression (Jaenisch &
Bird, 2003), but are also correlated with gene variants (Bell et al., 2012)
and environmental factors (Breitling et al., 2011). Our group has recently
demonstrated that even the microbe composition is partly under host
genetic influence (Goodrich et al., 2014). Similarly, all levels of omics data
are influenced by genetics as well as by environment and aging.
Correlations, however, do not only occur between but also within each
type of data. For instance, in genomics linkage disequilibrium, the
correlated occurrence of SNPs is a ubiquitous phenomenon. Transcription
factors often coregulate the expression of multiple genes (Allocco et al.,
2004), andmethylation patterns of neighbouring CpG siteswere reported
to be correlated (Bell et al., 2012). Metabolites are linked by a network of
biochemical reactions, causing strong correlations between them (Krum-
siek et al., 2011). Even phenotypes often cluster. Comorbidities, the over
proportional co-occurrence of diseases, were shown to affect many
diseases possibly through shared underlying mechanisms (Goh et al.,
2007).
These biological correlations can confound the associations and this is
a major issue of current research. For instance, 153 metabolites were
found by our group to be associated with age, but subsequent analyses
showed that only 22 of them are associated with age independently
(Menni et al., 2013b). Similarly, 21 of 24 measured IgG glycans were
correlated with age, but only 3 of them explain 58% of the variance
(Kristic et al., 2013). The same was found for epigenetic data (Weidner
et al., 2014). Huge lists of associations with aging are being unveiled
using all kinds of data, but the biologically interesting, causal associa-
tions are often obscured by this wealth of results. Approaches taking
simultaneously information from all omics levels into account are needed
to reconstruct the processes involved in aging on a systems level (Valdes
et al., 2013).
Even though high-throughput technologies are advancing and more
and more data are becoming available, integration of omics remains a
challenging problem. Besides the restricted availability of multi-omics
data sets for the same samples, technical limitations hamper the
integration process. While genomics and transcriptomics are able to
measure the entire set of variants, other omics (e.g. proteomics and
metabolomics) measure only a small fraction of all entities. Many high-
throughput technologies suffer from considerable technical variation
and strong batch effects. Stringent quality control and thorough data
normalization are crucial when analysing this type of data. Furthermore,
the complexity of the organism has to be taken into account. While the
genome is more or less stable, all other levels of omics change between
cell types and over time. Many samples, such as whole blood, contain a
mixture of different cell types with potentially different epigenomes,
transcriptomes (Houseman et al., 2012; Jaffe & Irizarry, 2014). Finally,
different organs and cells influence each other. The blood metabolome,
for instance, is heavily influenced by processes occurring in the liver or in
other organs, and multitissue samples are needed to fully understand
these. This in turn is not always feasible in an epidemiological setting as
collection of tissues often involves invasive procedures. Nevertheless,
data integration is an important and active field of research. A first step
of data integration is the integration and joint interpretation of separate
results. The Digital Ageing Atlas (Craig et al., 2014) summarizes more
than 4000 age-related changes across different technologies to facilitate
systems-level analyses of aging.
Introduction to systems biology
The aim of systems biology is to understand the system and its functions
as a whole rather than as separate components (Cassman, 2005), with
the final objective to mathematically model biological systems and
simulate their outcomes. As a first step, the complex interactions and
dependencies between these components must be formally described to
enable systematic analysis and simulation of the biological system of
interest. A technique widely used in systems biology is to translate
biological interactions into mathematically well-defined networks
(graphs). For instance, metabolites interact in chemical reactions, thus
forming a network in which nodes describe the metabolic compounds
Coregulation/
PPI
Genomics
Transcriptomics
PhenomicsMetabolomics
Epigenomics
Glycomics
Translation
Transcription
Enzyme activity
Gene silencing
Coregulation
LD
Comorbidities
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Proteomics
Fig. 1 Interdependencies of omics data: The figure illustrates dependencies which
can be observed within almost any omics data set. Solid lines indicate biological
processes which cause dependencies, while dashed lines represent observed
associations.
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and edges indicate chemical reactions. Similarly, transcription factors
bind DNA to control gene expression, forming the gene regulatory
network (GRN) and interacting proteins build a protein–protein interac-
tion network (PPI) (cf. Fig. 2B). These networks interact, making data
integration an important aspect of systems biology. One example for a
phenotypic network was created by Goh et al. (2007) using diseases as
nodes and connecting diseases with shared genetic risk factor by edges
(cf. Fig. 2A). By doing so, they showed that many disorders share a set of
underlying genetic risk variants and that similar diseases are caused by
similar genes.
Graphs can be explored using a variety of established algorithms. One
common task is the identification of modules, that is subgraphs in which
nodes share certain properties. In biological networks, modules corre-
spond to functional units, such as the glycolysis pathway in the
metabolic network. The modules are usually interconnected and
together form a hierarchical structure in which the distribution of node
degrees – the number of edges per node – follows the power law
(Baraba´si & Oltvai, 2004). Hence, most nodes have only few connections
and few nodes have many connections. These highly connected nodes
are called hubs (Albert et al., 2000; Jeong et al., 2001). Several other
measures exist to describe the topology of networks and topological
features of nodes. For example, the clustering coefficient measures how
densely the neighbourhood of a node is connected and thus highlights
nodes which are central within a cluster (e.g. LEPR in Fig. 2A). Another
measure is the betweenness centrality, which measures the proportion
of pairwise shortest paths containing a node. It thus quantifies the
importance of a node for connecting other nodes from different
modules (e.g. Parkinson’s disease in Fig. 2A and APOD in Fig. 2B). The
highly connected, central nodes are thought to be key players in the
system, connecting several modules and controlling network fluxes. They
were shown to be of particular importance for many diseases and
survival of the organism (Baraba´si & Oltvai, 2004; Joy et al., 2005; Yu
et al., 2007).
Many software packages for graph analysis and visualization are
publicly available. For instance, the R package igraph (Csardi & Nepusz,
2006) or the standalone program Cytoscape (Shannon et al., 2003) can
be used to analyse and visualize graphs. Cytoscape also provides easy
integration of biological databases such as Gene Ontology (Ashburner
et al., 2000), Reactome (Croft et al., 2014), the Kyoto Encyclopaedia of
Genes and Genomes (KEGG) (Kanehisa & Goto, 2000) or BioGRID
(Chatr-Aryamontri et al., 2013) by third-party apps. Several methods
were developed to identify modules of nodes which are jointly affected
by the condition of interest. Two publicly available examples are the
Cytoscape plugin jActiveModules (Ideker et al., 2002) and the R package
BioNet (Beisser et al., 2010).
Here, we present a selection of current methods to construct and
analyse biological networks as an approach to systems biology and their
impact on aging research.
Enrichment and network topology analysis in predefined
networks
A popular approach to put the results of an association study in a
systems biology context is projecting the variables of interest – such as
age-related genes, proteins or metabolites – onto known biological
(reference) networks. The neighbourhood of these target variables and
their topological properties can then be assessed using the experimen-
tally predefined PPI, GRN or metabolic networks. Instead of interpreting
individual entities separately, a priori knowledge about their interactions
and common functions can be used to identify modules that are jointly
affected by the condition of interest.
Several databases offer a collection of experimentally identified
interactions that can be used as predefined reference networks for
enrichment and topology. In case of PPI, the Human Protein Reference
Database provides more than 40 000 PPIs (Keshava Prasad et al., 2009),
the Database of Interacting Proteins more than 7000 interactions
(Xenarios et al., 2002) and the MIPS mammalian protein–protein
database roughly 1000 hand-curated interactions of human proteins
(Pagel et al., 2005). GRN are provided by the ChIPBase (Yang et al.,
2013), which contains six million transcription factor binding sites from
>300 experiments. Metabolic reactions are amongst others provided by
KEGG.
Enrichment analysis is a convenient way to incorporate existing
knowledge from biological reference networks without analysing graph
topology directly. Therefore, predefined (functional) modules within the
reference networks are used to test overrepresentation of associated
genes, proteins or metabolites in these groups. When investigating
genes, researchers usually use Gene Ontology to group genes based on
biological processes, molecular functions or subcellular localization. For
metabolites, the KEGG and Reactome databases provide curated
information about biochemical pathways. The R packages GSEABase,
GAGE (Luo et al., 2009) and the webservice MSEA (Xia & Wishart, 2010)
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Creutzfeld-Jacob
Parkinsons Disease
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Fig. 2 Topological Properties of Biological Networks (A) is an excerpt from the
human disease network (Goh et al., 2007). Nodes represent diseases; these are
connected if they are associated with the same gene. Parkinson’s disease connects
three isolated disease clusters (colours), thus having a low clustering coefficient
(0%) and high betweenness (72%). (B) is the close neighbourhood of the ApoD
protein in a PPI network from STRING DB (Franceschini et al., 2013) using only
experimentally confirmed interactions. ApoD connects two clusters and is, despite
the low degree (2) and clustering coefficient (0%), a central node (betweenness
centrality: 53%). In contrast, LEPR is central within the blue cluster (degree: 7,
clustering: 14%).
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are just some of many available implementations and variations in the
original gene set enrichment analysis (Subramanian et al., 2005)
algorithm.
In aging research, enrichment analysis unveiled an overexpression of
genes involved in immune response, lysosome and glycoproteins and an
underexpression of mitochondrial- and oxidative phosphorylation-related
genes in old people compared with young (de Magalh~aes et al., 2009).
In human brain tissue, oxidative stress/DNA repair and inflammation-
related genes were shown to be enriched in the set of differentially
expressed genes between young and old individuals (Lu et al., 2004).
Enrichment analysis facilitates the identification of pathways that are
important for the aging process. It thus helps to make sense out of the
individual associations and find biological interpretations for the
observed molecular changes.
To become independent of predefined module annotation and to
enable more detailed network analysis, the variables of interest can also
be mapped directly on the known PPI, GRN or metabolism networks.
Modules can then be identified dynamically based on the measured
data. Moreover, additional topological properties of the variables of
interest can be assessed.
Studying human PPI networks revealed that genes that are associated
with aging by homology have higher node degrees and higher
betweenness centrality compared with other genes (Bell et al., 2009).
Furthermore, aging-related genes are not spread throughout the
interactome, but cluster in few tightly connected modules. These
modules were enriched in DNA damage repair and stress response genes
(Kriete et al., 2011). The high connectivity of aging genes was used by
Tacutu et al. (2012) to select neighbours of longevity-related genes in a
PPI network as longevity-gene candidates. Subsequent experiments in
C. elegans revealed 30 new longevity-associated genes, proving the
potential of network biology for candidate gene selection. Using a
modified PPI network, Wang et al. (2009) showed a tight connection of
the genetic causes of aging and disease. These results indicate that aging
does not occur due to random errors but is an organized process.
Another PPI-based approach to data integration was developed by West
et al. (2013). They incorporated epigenomic data by assigning DNA
methylation sites to each protein in the graph and then identifying
modules of differentially methylated genes/proteins in the resulting
network. By doing so, they avoided predefined gene sets as used by
enrichment analysis. The analysis revealed three differentially methylated
modules, which were replicated across several tissues. Two of them
contained mainly transcription regulating genes, while the third one
contained genes related to stem cell differentiation.
A drawback of experimentally derived PPI or GRN is that such
methods detect up to 50% false positives while many true interactions
are missed (Huang & Bader, 2009; Marbach et al., 2012). Even more
importantly, those reference networks completely ignore the tempo-
spatial properties of the interactions. This restricts results to already
observed, possibly inactive interactions. One method to overcome the
static nature of PPI networks are Negative–Positive (NP) networks (Xia
et al., 2006). These integrate the PPI network with transcriptomics data
by restricting it to edges between (anti-)correlated proteins/genes.
Therefore, only those interactions (=edges) that are active under the
observed condition are further analysed. Xue et al. (2007) applied this
method to the previously mentioned data set of brain gene expression
and unveiled two anticorrelated modules containing cell proliferation-
and cell differentiation-related proteins. Two other modules consisting of
protein processing and immunity-related genes, respectively, were found
to be slightly correlated with the cell proliferation module. A recent study
went one step further and restricted a PPI network to highly expressed
genes in different stages of aging for each sample separately, thus
generating a set of dynamic binding networks instead of a single
network. Even though the global properties of all those graphs were very
similar, the centrality of several genes correlated with age (Faisal &
Milenkovic, 2014).
Incorporating biological networks to analyse aging-related changes
showed the tight connection of aging and disease on a molecular level.
Furthermore, it has been shown that aging affects central genes, which
are important for the network integrity (Bell et al., 2009). While
network-based enrichment and analysis using PPI networks is common
for genetic and transcriptomics data, it has not been applied to aging
studies using metabolomics data. This could be a promising approach to
systematically identify metabolic pathways jointly affected by the aging
process.
Analysis of data-derived networks
Despite their successful applications, all approaches presented so far
rely on predefined, static networks. To overcome the limitations of
such networks, inferring networks directly from the measured data is
the next step.
Weighted gene co-expression network analysis
The weighted gene co-expression network analysis (WGCNA) (Zhang &
Horvath, 2005) infers gene–gene interaction networks directly from
transcriptomics data. Miller et al. (2008) applied this method to the
previously mentioned gene expression data set of 30 human frontal
cortex samples at different ages and then compared the results with a
network derived from an AD transcriptomics study. It revealed significant
overlap between healthy aging and AD, suggesting that there might be a
shared molecular basis for both processes. Three AD network modules
overlapped with aging network modules, containing mostly synapses-,
transport- and transcriptional regulation-related genes.
Gaussian graphical models
Despite the successful application of WGCNA on transcriptomics data,
Krumsiek et al. (2011) showed that ordinary correlations are not suitable
to analyse metabolomics data from large cohort studies. They analysed
metabolite concentrations of >1000 samples and found that more than
half of all pairs of 151 metabolites correlated significantly, even when
using a restrictive Bonferroni correction at an alpha level of 0.01. This is
largely due to indirect associations, which cannot be distinguished from
direct associations by the Pearson correlation coefficient. Graphical
models (GMs), also known as conditional independence graphs, were
proposed to overcome this problem and infer biological meaningful
networks from metabolomics (Steuer, 2006; Krumsiek et al., 2011) as
well as other omics data (de la Fuente et al., 2004; Yuan et al., 2011;
Mangin et al., 2012). GMs are probabilistic models where an edge
between two variables illustrates their conditional dependence given all
other variables in the model. Implicitly, the absence of an edge
represents the conditional independence of the according variables.
Several algorithms to infer GMs from purely binary data are publicly
available as R packages (Wainwright et al., 2006; Ho¨fling & Tibshirani,
2009; Guo et al., 2010; Ravikumar et al., 2010). Their counterparts for
purely continuous data are Gaussian graphical models (GGMs), which
use partial correlations to infer graphs. A partial correlation of two
variables X and Y conditioned on a set of variables Z quantifies the
portion of the correlation between X and Y which cannot be attributed
to Z. Several algorithms exist to infer GGMs (d’Aspremont et al., 2006;
Meinshausen & Bu¨hlmann, 2006; Yuan & Lin, 2007; Friedman et al.,
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2008; Mazumder & Hastie, 2012). Several of them, such as the well-
established graphical lasso (Friedman et al., 2008; Mazumder & Hastie,
2012), use regularization to further reduce the number of edges in the
graph. This allows researchers to concentrate on fewer high-confidence
interactions.
Gaussian graphical models can reconstruct biological pathways from
metabolomics and transcriptomics data, but have not yet been applied in
aging research. However, their application could help reduce the
‘overabundance’ of results to fewer, meaningful associations. The major
drawback of GMs is that they can only be used for pure Gaussian or pure
binary data. Shin et al. (2014) overcame this problem by first construct-
ing a GGM from metabolite concentrations and then adding gene
variants as nodes and connecting them with associated metabolites. The
resulting network illustrates the genetic control of the metabolism in an
intuitive way. However, it is no longer a GM, and edges do not indicate
conditional independence any more.
Mixed graphical models
Recent developments allow the integration of different types of data
while maintaining the favourable properties of GGMs, namely mixed
graphical models (MGMs) (Tur & Castelo, 2012; Chen et al., 2013;
Fellinghauer et al., 2013; Lee & Hastie, 2015). Fellinghauer et al. (2013)
proposed a very flexible algorithm based on stability selection (Mein-
shausen & Bu¨hlmann, 2010). It makes use of established methods such
as random forests or regression models to rank interactions between
variables of different types. Thus, it can handle many different data types
such as disease states, metabolite levels and gene variants. Due to the
usage of stability selection, it has an intrinsic error control. MGMs
provide a powerful tool for multivariate analyses of high-dimensional
data, but have not been applied in biological research, yet. Their
application could shed light on the complex relationship between aging
and disease.
Gaussian graphical models as well as MGMs are undirected models.
Therefore, neither of them can be used to infer causal direction. In
epidemiological research, Mendelian randomization is a common
approach to infer causality from observational data. It takes advantage
of the invariability of gene variants to separate the study population in
groups, thus mimicking a randomized controlled trial (for further details,
see Brion et al., 2014). Mendelian randomization can be used to further
investigate edges of interest that were previously identified by GMs.
However, it relies on stable associations with genetic variants and
assumes that this genetic variant is not related to any other potential
confounding factor. Due to these restrictions, it is not suitable to infer
large-scale networks.
Bayesian networks
Another approach that allows inferring causality from observational data
under certain assumptions is based on Bayesian networks (BNs). Similar to
GGMs, BNs are probabilistic models in which edges represent the
conditional independence between variables. However, BNs are DAGs,
thus distinguishing between an influence of X on Y and the influence of Y
on X. In return, the acyclicity of the causal graph is an assumption which
might not hold true for biological networks. The application of BNs on
high-throughput transcriptomics data by Friedman et al. (2000) demon-
strated the potential of this method to extract biological meaningful
associations without prior knowledge. Several different methods are
available to estimate the structure of BNs from binary, continuous and
even mixed data such as the R packages bnlearn (Scutari, 2010) (Table 1).
The methods presented here are just a selection of the available
methods for graph inference. Several other methods such as Boolean
networks (Shmulevich et al., 2002) or differential equation systems
(Chen et al., 1999; Lorenz et al., 2009) are commonly used for
modelling biological networks.
The development of new techniques facilitates graph inference from
high-dimensional data, and the presented studies illustrate their useful-
ness in biological research. However, most graph inference methods rely
on large sample sizes and usually more samples than variables are
needed. When analysing omics data, particularly genomics or transcrip-
tomics, this is often not feasible and it is referred to as the np problem.
Another common problem is overfitting of models due to the high
number of parameters. Some techniques such as regularization have
been proposed to relax these constraints and reduce overfitting.
Nevertheless, stringent cross-validation and replication in independent
cohorts should be employed to avoid spurious results. Finally, many high-
throughput methods suffer from considerable technical variation and
strong batch effects. Researchers should carefully normalize all mea-
Table 1 Overview over system biology methods and their application in aging
Method Prerequisites Applies to Availability Application
Enrichment Analysis Module definition (e.g. gene sets from Gene
Ontology)
Genomics
Transcriptomics
Proteomics
Metabolomics
Several R packages (e.g.
GSEABase, GAGE, MSEA),
online tools DAVID or Enrichr
Lu et al. (2004), de Magalh~aes
et al. (2009)
Network Mapping Predefined network, such as protein–protein
interaction (PPI) networks, gene regulatory
network (GRN) or metabolic network
Any omics data R package igraph, Cytoscape
with various plugins
Wang et al. (2009), Bell et al.
(2009), West et al. (2013), Faisal
& Milenkovic (2014)
NP Networks PPI Network Transcriptomics – Xue et al. (2007)
Weighted Gene Co-
Expression Network
Analysis (WGCNA)
– Transcriptomics (and
possibly other
continuous data)
R package WGCNA Miller et al. (2008)
Gaussian graphical
models (GGMs)
– Any multivariate
Gaussian
distributed data
Several R packages (e.g. ggm or
glasso)
Applied to metabolomics data by
Krumsiek et al. (2011)
Mixed graphical
models (MGMs)
– Binary, continuous
and mixed data
–
Bayesian Networks – Binary, continuous
and mixed data
Several R packages (e.g.
bnlearn, gRain, abn, deal)
Applied to transcriptomics data
by Friedman et al. (2000)
Integration of omics data in aging research, J. Zierer et al. 939
ª 2015 The Authors. Aging Cell published by the Anatomical Society and John Wiley & Sons Ltd.
surements according to current standards before integrating different
data sets.
Model biological systems
The ultimate goal of systems biology is not only the qualitative
exploration, but the quantitative modelling of the organism, facilitating
in silico experiments, hypotheses generation and predictions.
The first – and so far only - attempt to model a whole organism was
conducted by Karr et al. (2012). They created a model of a mycoplasma
genitalium cell simulating cell cycle and predicting metabolite concentra-
tions. However, the model is far from perfect (Freddolino & Tavazoie,
2012) and too primitive to be adapted to more complex organisms.
Currently, modelling eukaryotic cells or even whole organisms is not
feasible. Also, processes like aging are too complex to be entirely
modelled. However, some effort has been undertaken to create network
representations of smaller subsystems as well as certain aspects of the
aging process. For instance, Gillespie et al. (2004) simulated aging of yeast
based on the accumulation of extrachromosomal ribosomal DNA circles.
Also, Oda & Kitano (2006) summarized results from several hundred
studies to create amodel of the Toll-like receptor (TLR) signalling network.
The same group also created a similar model for epidermal growth factor
receptor signalling (Oda et al., 2005). Both studies revealed a bowtie-like
global structure with one important key regulator. However, both
networks are only qualitative descriptions without kinetic parameters.
Thus, they cannot be used for computer simulations.
Other groups concentrated on even smaller subsystems to facilitate
quantitative modelling. One study investigated the influence of increased
cortisol levels on hippocampus activity (McAuley et al., 2009). A
quantitative model was created to simulate the decline in hippocampal
output with age and the acceleration of this process due to acute and
chronic increases in cortisol levels. Simulations using ordinary differential
equations suggested that chronic increase in cortisol levels leads to faster
decline in hippocampal output than acute bursts, but could be treated
more efficiently. Sozou & Kirkwood (2001) modelled cell senescence
based on telomere shortening and oxidative stress. The same group also
described the influence of chaperones and accumulation of misfolded
proteins on aging (Proctor et al., 2005). Other groups investigated
various further aspects of the aging process, such as mitochondrial
fusion and fission events and accumulation of defective mitochondria
(Kowald et al., 2005; Figge et al., 2012), incomplete replication of
epigenetic information (Przybilla et al., 2014) and age-related alterations
in the lipid metabolism (McAuley & Mooney, 2015). Adjusting the
kinetics of such models to correspond to experimental observations
allows to come up with plausible hypotheses about the causes of aging.
In contrast to earlier presented networks, which inferred large-scale
networks from data (top-down approach), these approaches model
small subsystems in high details based on expert a priori knowledge
(bottom-up approach). Such bottom-up models allow mechanistic
insights into the processes of aging that cannot be generated by
individual association studies. Moreover, they facilitate the development
of new hypothesis and testing the plausibility of current hypothesis.
Conclusions and challenges
The major recent advances of omics technologies are now enabling the
simultaneous measurement of millions of biochemical entities. Associ-
ation studies have revealed many associations of omics data with aging
and age-related diseases. After decades of reductionist studies, network
analysis and integrated omics data analysis have begun to target the
aging process at a systems level. As a result, some studies take into
account also the interaction effects between variables. However, given
the complexity of aging, new methods are needed to further unveil the
multiple interactions.
Systems biology already provides such methods, but their application
on real biological problems lags behind. For example, GGMs have been
adapted to mixed data types and could readily be applied in aging
research. Also, several studies developed models of processes that
contribute to aging. These provide detailed knowledge about important
components of the aging process and their interactions. Building on
these results, future studies should aim to integrate these different parts
to gain a more systems-level understanding of aging.
However, in many cases, the available data limit the possibilities.
Problems such as incomplete data, asynchronous experiments, strong
batch effects and insufficient sample sizes have to be dealt with. Another
issue is the limited availability of multi-omics data sets, which compli-
cates replication of results in this field. A variety of different methods,
protocols and platforms further hampers reproducible results. As
replication of results is crucial to prevent spurious results and validation,
methods like splitting the available data into discovery and replication
sets should be considered more often.
Despite these obstacles, there are several large population studies in
existence with multi-omics data available which could be explored using
systems biology approaches. For instance, the GTEx project aims to
collect gene expression and methylation data from multitissue samples
(The Gtex Consortium 2013). Simultaneously, the development of new
methods should help to analyse real, partially incomplete data sets and
facilitate analysis of multitissue and multi-organ data, thus enabling the
investigation of real systems-level effects. Addressing these problems
and developing integrated models of aging should improve our
understanding of the aging process, thus allowing the development of
strategies to improve health in old age.
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